Opioid Prescribing Patterns and Complications in the Dermatology Medicare Population

Abstract

IMPORTANCEThe ongoing opioid epidemic in the United States has been fueled by prescription opioids. Increases in opioid-related deaths and complications mandate clinicians in all fields to scrutinize their prescribing patterns. OBJECTIVE To characterize the current status and potential complications of opioid prescribing practices among dermatologists for Medicare beneficiaries. DESIGN, SETTING, AND PARTICIPANTSA cross-sectional study used Medicare Part D prescriber data to evaluate opioid prescriptions by dermatologists from January 1 to December 31, 2014. The number of prescribers, opioid claims, beneficiaries, and days supplied as well as the type of opioid and geographic location of prescribers were extracted and analyzed. The top 1% of dermatologists prescribing opioids were identified and compared with a random sample of the same size among the remaining dermatologists based on sex, geographic location, type of practice, and time in practice. A systematic literature review was conducted to estimate the outcome of opioid prescribing practices on the exposed population.MAIN OUTCOME AND MEASURES Practice characteristics, epidemiologic factors, and consequences of opioids prescribed by dermatologists. RESULTSOf the 12 537 dermatologists in the study, 5305 (42.3%) prescribed no opioid claims, 5408 (43.1%) prescribed 1 to 10 opioid claims, and 1824 (14.5%) prescribed more than 10 opioid claims. Among dermatologists prescribing at least 10 opioid claims, a mean of 1.0 opioid claims was given to each beneficiary, with a supply lasting a mean of 4.4 days. A total of 108 dermatologists (93.9%) in the top 1% of opioid prescribers (n = 115) work in a surgical practice. Estimates suggest that opioids prescribed by dermatologists could annually lead to 3877 to 7602 beneficiaries continuing to use opioids at 1 year and 1825 to 4209 continuing to use opioids at 3 years. A total of 9882 to 22 806 beneficiaries could experience gastrointestinal tract or central nervous system adverse effects and 588 to 999 could experience fractures. CONCLUSIONS AND RELEVANCE Opioid prescribing among dermatologists is limited and concentrated in the surgical setting, but it may be associated with a substantial number of adverse events that serve as a reminder to emphasize nonopioid pain medications in the postoperative setting.Role of the Funder/Sponsor: The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. 30.Sniezek PJ, Brodland DG, Zitelli JA. A randomized controlled trial comparing acetaminophen, acetaminophen and ibuprofen, and acetaminophen and codeine for postoperative pain relief after Mohs surgery and cutaneous reconstruction.

Are Opioids Out? Assessing Prescription Patterns in Plastic Surgery Using Medicare Part D Beneficiary Data

“…In dermatology and radiation oncology, those practicing in the South had higher opioid prescribing rates than those in other regions. 14,16 Because plastic surgery is a surgical subspecialty, physicians may be more cognizant of multimodal pain management and, as a result, may tend to have lower prescriber rates than in other specialties. Furthermore, disparities in opioid prescriptions across regions are likely influenced by social determinants of health, including race, income level, insurance status, and urbanization.…”

Liposomal bupivacaine infiltration as an effective option for postoperative pain management after Mohs surgery

“…1 Diarrhea and incontinence are symptoms commonly encountered during the early postoperative period, but the presence of JEDD is very unusual. 2 We present herein three patients (6, 3, and 2 years old) operated several times for HD which showed posterior complications. They developed perianal lesions that became chronic, displaying an erosive aspect (Fig.…”

“…1 Furthermore, prescription opioid use often precedes opioid misuse and addiction. 2 While overprescription creates the potential for adverse effects and misuse, inadequate pain control can lead to a poor patient experience. One solution is a long-acting injectable analgesic such as liposomal bupivacaine, especially in those with potential for toxicity, misuse, or known contraindications to opioids.…”

“…However, opioids have significant side effects, including vomiting, ileus, respiratory and central nervous system depression, tolerance, and dependence 1 . Furthermore, prescription opioid use often precedes opioid misuse and addiction 2 . While overprescription creates the potential for adverse effects and misuse, inadequate pain control can lead to a poor patient experience.…”

Rates of Opioid Prescriptions Obtained After Mohs Surgery

“…A mong dermatologists, dermatologic surgeons prescribe the majority of opioids. 1,2 Most dermatologic surgeons limit opioid supplies to 4 to 5 days. 1,2 However, it has been demonstrated that even short courses of opioids may significantly increase addiction risk.…”